ENST00000521599.5:c.-20+15007T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000521599.5(NCALD):​c.-20+15007T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.33 in 151,740 control chromosomes in the GnomAD database, including 9,908 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 9908 hom., cov: 32)

Consequence

NCALD
ENST00000521599.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.410

Publications

1 publications found
Variant links:
Genes affected
NCALD (HGNC:7655): (neurocalcin delta) This gene encodes a member of the neuronal calcium sensor (NCS) family of calcium-binding proteins. The protein contains an N-terminal myristoylation signal and four EF-hand calcium binding loops. The protein is cytosolic at resting calcium levels; however, elevated intracellular calcium levels induce a conformational change that exposes the myristoyl group, resulting in protein association with membranes and partial co-localization with the perinuclear trans-golgi network. The protein is thought to be a regulator of G protein-coupled receptor signal transduction. Several alternatively spliced variants of this gene have been determined, all of which encode the same protein; additional variants may exist but their biological validity has not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000521599.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000521599.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NCALD
NM_001040624.2
c.-106-13575T>C
intron
N/ANP_001035714.1P61601
NCALD
NM_001040625.2
c.-20+15007T>C
intron
N/ANP_001035715.1P61601
NCALD
NM_001040626.2
c.-106-13575T>C
intron
N/ANP_001035716.1B2RB70

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NCALD
ENST00000521599.5
TSL:1
c.-20+15007T>C
intron
N/AENSP00000428105.1P61601
NCALD
ENST00000311028.4
TSL:5
c.-106-13575T>C
intron
N/AENSP00000310587.3P61601
NCALD
ENST00000395923.5
TSL:5
c.-20+15007T>C
intron
N/AENSP00000379256.1P61601

Frequencies

GnomAD3 genomes
AF:
0.330
AC:
49991
AN:
151622
Hom.:
9886
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.544
Gnomad AMI
AF:
0.150
Gnomad AMR
AF:
0.352
Gnomad ASJ
AF:
0.247
Gnomad EAS
AF:
0.392
Gnomad SAS
AF:
0.318
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.223
Gnomad NFE
AF:
0.221
Gnomad OTH
AF:
0.294
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.330
AC:
50061
AN:
151740
Hom.:
9908
Cov.:
32
AF XY:
0.329
AC XY:
24410
AN XY:
74162
show subpopulations
African (AFR)
AF:
0.544
AC:
22495
AN:
41388
American (AMR)
AF:
0.352
AC:
5359
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.247
AC:
858
AN:
3468
East Asian (EAS)
AF:
0.392
AC:
2021
AN:
5156
South Asian (SAS)
AF:
0.317
AC:
1525
AN:
4814
European-Finnish (FIN)
AF:
0.185
AC:
1954
AN:
10544
Middle Eastern (MID)
AF:
0.216
AC:
63
AN:
292
European-Non Finnish (NFE)
AF:
0.221
AC:
15021
AN:
67836
Other (OTH)
AF:
0.300
AC:
628
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1567
3134
4701
6268
7835
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.263
Hom.:
696
Bravo
AF:
0.353

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
6.4
DANN
Benign
0.83
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs517868;
hg19: chr8-102913030;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.